Purpose of review Although infection rates have modestly decreased in the neonatal intensive care unit (NICU) as a result of ongoing quality improvement measures, neonatal sepsis remains a frequent and devastating problem among hospitalized preterm neonates. Despite multiple attempts to address this unmet need, there have been minimal advances in clinical management, outcomes, and accuracy of diagnostic testing options over the last 3 decades. One strong contributor to a lack of medical progress is a variable case definition of disease. The inability to agree on a precise definition greatly reduces the likelihood of aligning findings from epidemiologists, clinicians, and researchers, which, in turn, severely hinders progress toward improving outcomes.
INTRODUCTION
In 2010 worldwide, 7.6 million children less than 5 years old died, predominantly because of infectious causes including sepsis; neonatal deaths (in the first 28 days of life), accounted for 40% of the total lives lost [1] . In 1990, both the United Nations and World Health Organization (WHO), prioritized a two-third reduction in the unacceptable child mortality rate by 2015. However, in 2013, 44% of deaths in children under the age of 5 occurred during the neonatal period, up from 37% in 1990. Despite major advances in neonatal care and increasing research, in developed countries, 4 out of every 10 infants with sepsis die or experience major disability, including significant permanent neurodevelopmental impairment [2] .
Prematurely born neonates experience the highest incidence and mortality of sepsis among all age groups [3] [4] [5] [6] [7] [8] . In the United States, a staggering 36% of neonates born before 28 weeks completed gestation suffer at least one episode of blood stream infection (BSI) during their birth hospitalization, with up to a 50% associated mortality [3] . Compared with term infants, sepsis in preterm infants is up to 1000-fold more common and is associated with higher rates of mortality and life-long neurodevelopmental handicaps [4, [9] [10] [11] [12] [13] . Of note, it is estimated that 11% of the 135 million births globally occur before 37 weeks competed gestation (preterm), and preterm births have been increasing steadily, especially in developed countries [1, 14] .
Common laboratory tests (including the white blood cell indices, acute phase reactants, and heartrate characteristics) have limited diagnostic accuracy [low positive predictive value (PPV)] for neonatal sepsis [15] [16] [17] [18] . This limitation in ancillary test accuracy, in combination with the subtle, ambiguous early clinical signs that overlap with the premature infant's struggle to survive after leaving the womb too early, strongly compel neonatologists to 'rule-out sepsis'. This clinical entity is the most common diagnosis and its treatment (antibiotics) are the most commonly used medications in the neonatal intensive care unit (NICU) [19] . If antimicrobial therapy is withheld until the infant is overtly symptomatic, outcomes are dismal [20] ; however, liberal antimicrobial use is also associated with adverse clinical outcomes beyond the selection of resistant microorganisms [21] [22] [23] [24] .
Attempts over the last 30 years by research teams, including thousands of infants and their families, alongside basic science and clinical investigators, have not generated significant improvements in diagnostic and prognostic accuracy, clinical management, or outcomes for neonatal sepsis. Although the dynamic nature of sepsis in the context of developmental immaturity has undoubtedly played a role in limiting our diagnostic testing accuracy, a variable case definition for any pathologic condition should be expected to retard progress [25] .
A case definition is paramount for understanding the epidemiology (incidence, prevalence) and impact (short-term and long-term outcomes, mortality) of any disease. In addition, a disease definition is critical for the selection of patients for clinical trials that will examine diagnostic and prognostic testing methods and the effect of interventions on the impact of the disease. Finally, a disease definition is important for education (of epidemiologists, scientists, and providers) and for benchmarking hospital outcomes and the quality of patient care. Clear and accepted disease definitions have been established for several other major complications in neonatology including retinopathy of prematurity [26] , necrotizing enterocolitis [27] , respiratory distress syndrome [28] , chronic lung disease [29] , intraventricular hemorrhage [30] , PDA [31] , and hypoxic-ischemic encephalopathy [32] . Assessment of the impact of treatment strategies on outcomes for these conditions required concerted efforts that could only be accomplished through the development and acceptance of definitive criteria. Even when investigators use consensus definitions of disease, the impact of issues affecting external validity following well designed and executed randomized controlled trials is well documented [33] . The absence of definitive accepted criteria for sepsis in neonates, and especially in preterm infants, makes the implementation of future studies and interpretation of their results difficult, or even impossible, for organizations, centers, and investigators that use different criteria. If the case definition for a disease is a moving target, is it reasonable to expect valid and reproducible laboratory-based diagnostic and prognostic testing to emerge?
NEONATAL SEPSIS IS VARIABLY DEFINED
There is remarkable heterogeneity among studies regarding the case definition of neonatal sepsis [34] . The presence of a positive blood culture historically constitutes the 'gold standard' for the presence of neonatal sepsis [34] . This conclusion requires at least 2 assumptions: the infant would not have been evaluated for sepsis (have a blood culture drawn and sent) in the absence of concerning clinical signs that are representative of a systemic inflammatory response syndrome (SIRS); the isolated bacteria did not represent contamination (type I error). Often, the presentation of persistently abnormal clinical signs or inflammatory biomarkers to substantiate the presence of SIRS/sepsis are not recorded or included [34] . In a study of 2416 very low birth weight, premature infants (VLBW, <1500 g at birth, mean gestational age <29 weeks at birth) with clinical and laboratory features compatible with late onset sepsis (LOS), the overwhelming majority of the infants that did not have proven LOS [35] . Specifically, of the 13 clinical and laboratory signs reported in that study, the median PPV was 16.8% (25th percentile, 14.8; 75th percentile, 20.2), and the maximum PPV of any clinical or laboratory sign presented was 31.3% (neonatal hypotension). These data suggest that, in most cases, individual clinical signs are not associated with a positive blood culture result. A similar PPV was shown in a smaller study, which used model development and validation
KEY POINTS
Neonatal sepsis is a common, devastating, and expensive disease with life-long impact plagued by a lack of accurate diagnostic and prognostic testing. Management options and outcomes have not changed for the last 30 years.
There is remarkable heterogeneity among studies regarding the case definition of neonatal sepsis.
A variable definition of disease severely limits the pace of progress for these important endeavors.
Pediatric consensus definitions for sepsis are not accurate for term neonates and were not designed for preterm neonates.
The development and acceptance of a consensus definition for neonatal sepsis is an important and necessary step towards the goal of improving outcomes.
cohorts for individual signs [36] . In that study, the acute onset of three or more signs (clinical or laboratory, or a combination) was associated with a modest sensitivity of 61.5% and a specificity of 76.2% for a positive blood culture.
The majority of sepsis evaluations that are prompted by concerning clinical signs are associated with negative blood culture results. Hornik et al. [37] reported that of 164,744 blood cultures obtained from 99,796 VLBW infants with suspected LOS, just 8.9% were positive. These data strongly suggest that the occurrence of the 'gold standard' is very rare when clinical concerns prompt an evaluation. Beyond the evaluations performed on preterm infants with ambiguous clinical signs, a sepsis evaluation (blood culture) performed on asymptomatic at-risk term neonates is a daily occurrence that is not well supported by recent data [38] .
As many as 62% of extremely low birth weight infants (<1000 g) who survive >12 h after birth have a positive blood culture during their hospitalization [4] . Coagulase-negative Staphylococci (CoNS) represents greater than 50% of isolated bacteria from blood cultures of preterm infants in the United States and many centers worldwide [6, 13, 37] . The recent report describing the 'rise and fall' of CoNS suggests that many culture positive cases of presumed CoNS bacteremia may either represent episodes of contamination or central line colonization and that this possibility should be a consideration in the development of a useful definition for neonates [39] .
When blood and other sterile site cultures are negative, but the infant manifests signs consistent with infection, they may be considered to have 'clinical' sepsis. Importantly, a positive blood culture is not required to meet the consensus definition for sepsis in adults and children [40, 41] . In fact, a pathogen may be identified in as little as 36-51% of cases of sepsis in adults [42, 43] even though sepsis is defined as SIRS in response to an inciting infection. A similar rate of culture-negative sepsis is seen in pediatric patients even in the setting of shock [44] . In a study of newborns with unequivocal infection documented at autopsy, premortem blood cultures were negative in 14% of cases [45] . In another study of 92 neonates greater than 34 weeks with documented bacterial meningitis, 35 (38%) had negative blood cultures [46] . However, there is a lack of clear and accepted criteria that must be met to support a diagnosis of neonatal clinical sepsis in practice and in research. In neonates, this clinical scenario is far more common than blood-culture positive sepsis [47] , and represented nearly 60% of the patients enrolled in the recent International Neonatal Immunotherapy Study (INIS) that examined the treatment of neonatal sepsis with intravenous immune globulin [2] . Outside of a false negative result (type II error) [48] , the possibility of a nonbacterial cause of sepsis must also be considered as a microbial cause for clinical sepsis. Fungal and viral infections may also generate SIRS and cause sepsis. There is increasing evidence for novel viral pathogens associated with sepsis-like syndrome in preterm infants (e.g., echovirus, enterovirus, parechovirus, coxsackie, adenovirus, parainfluenza, rhinovirus, coronavirus) [49] [50] [51] [52] . A prospective cohort study that included 100 infants evaluated and treated for late-onset sepsis demonstrated that 8% had a respiratory virus detected at the time of the sepsis evaluation [53] . None of the patients had a respiratory virus with concurrent bacteremia and the incidence of bacteremia was 15% (15/100). These studies indicate that viral infections are contributing to some episodes of clinical deterioration that are associated with a negative blood culture. Evaluation for the presence of nonbacterial pathogens is an important consideration for a definition of neonatal sepsis and, in particular, clinical sepsis.
CONSENSUS SEPSIS DEFINITIONS ARE WIDELY USED BY PEDIATRIC AND ADULT INTENSIVISTS
Adult and pediatric intensivists currently use consensus definitions for sepsis for goal-based therapeutic interventions [40, 41, 54, 55] . Many consensus definitions for disease are in place or sought after across multiple disciplines of medicine and are often the result of international collaboration [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] . The pediatric consensus definition for sepsis, established in 2005 to support the trial of activated protein C for the treatment of pediatric sepsis, was intended for all children (<18 years old) and including term (>37 weeks completed gestation) neonates [41] . Preterm neonates (<37 weeks completed gestation) were specifically excluded from the pediatric consensus definitions and neonatal-perinatal subspecialists were not represented among the international pediatric consensus experts. The adult and pediatric consensus definitions for sepsis stipulate that evidence of SIRS be present as a prerequisite to meeting criteria for sepsis. SIRS requires either abnormal WBC count (total WBC increased or decreased for age or >10% immature neutrophils) or abnormal core temperature (>38.5 or <368C) [41] . Hofer et al. [66] retrospectively examined 476 term neonates to investigate if the pediatric consensus definitions for SIRS and sepsis applied to term infants and found that the consensus definitions applied to only 53% of cases of culture-positive early-onset sepsis (EOS). Although the accuracy of the pediatric consensus definitions has not been assessed in preterm infants, using these criteria is untenable because of several limitations related to the developmental maturity of preterm infants [34] . The establishment of an initial consensus definition for sepsis in neonates will most certainly build on the experiences from our pediatric and adult colleagues through the use of modern molecular techniques for pathogen detection, characterization of the host response, and integration of a severity of illness scoring system [34] .
THE TARGET AUDIENCE FOR THE CASE DEFINITION IS AN IMPORTANT CONSIDERATION
When choosing a case definition, an important consideration is how well the definition fits the needs and resources of investigators and clinicians. For example, clinicians would benefit most by a threshold (static) definition that includes clinical and laboratory signs, but does not require specialized laboratory testing. Uniquely, this group is the largest of the target audiences and has to make a decision in real-time of whether to initiate treatment or continue close observations. In contrast, it may appear that an epidemiologist has the benefit of retrospection to identify disease incidence and prevalence. However, one that examines national and global statistics would have neither reliable access to patient-specific granular data such as the specific presence or duration of clinical/laboratory signs, nor the time required to verify that appropriate clinical and laboratory requirements were met in each case because the majority of their data is extracted from coding records (ICD-10) and death certificates [67, 68] . Basic science and clinical researchers would likely require the greatest degree of detail to accurately characterize the index population seen in observational studies so interventions can be tested in clinical trials on similar patients. A number of subdefinitions should be expected to evolve as data were collected to accommodate pathogen, sex, and developmental age groupspecific criteria.
CONSENSUS DEFINITIONS ARE NOT MEANT TO BE THE LAST WORD
Consensus definitions have the potential to unify investigators so that their respective findings can be verified and built upon. However, consensus definitions are not without limitations [69, 70] . Present consensus definitions for sepsis in children and adults are threshold-based and thus static. Although the change in clinical status over time (disease velocity) can be very informative, time is often not available to inform the static decision to enroll a patient in a prospective interventional trial. This limitation may be particularly relevant to the newborn that is transitioning to extrauterine life with resolving respiratory distress. Thus, a static definition of sepsis will be associated with continued limitations in diagnostic accuracy because sepsis is a dynamic, complex, and heterogeneous condition [71] . To study the impact of disease velocity, the change in status over time (e.g. time of clinical presentation/biomarker measurement, duration of clinical and laboratory signs) should be collected in diagnostic and observational studies. Using prospective data collection with retrospective classification to a consensus definition of disease, our attention is focused first on definitive disease and improving our understanding of the pathophysiology. A more complete knowledge base will lead to improved diagnostic and prognostic testing that will, in turn, inform the design and implementation of quality randomized controlled trials.
It is not unreasonable when there are limited data to begin with clinical consensus and move to evidence based definitions [72] . Importantly, a consensus definition should only defer to expert opinion when data are not available. An important aspect of any useful case definition is the need for revision and refinement as new data are acquired [59, [73] [74] [75] [76] [77] [78] . Thus, a consensus definition is not meant to be the last word on how to define sepsis. Rather, the establishment of an accepted definition to be used by clinical researchers is but the first of many steps towards improving outcomes for neonates with sepsis. While considering other potential limitations of consensus definitions [34] , it is worth asking how many limits on progress are we presently accepting with a static and variable definition of neonatal sepsis?
CONCLUSION
Neonatal sepsis remains a significant global problem with little progress made despite major efforts. A variable case definition of disease can only serve to reduce the impact of investigation, and obstruct advances that are so sorely needed. To unify investigators globally and accelerate the pace toward improved outcomes, we must first develop and validate an accepted consensus definition for neonatal sepsis.
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